Insider · CIK 0002127198
Glenn Gormley
Files at AKTS (Aktis Oncology, Inc.). First filing -, latest -.
In brief
Glenn Gormley files SEC Form 4 as director at AKTS (Aktis Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Glenn Gormley has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | AKTS Aktis Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,866 | $0.00 | $0 | 37,866 | Apr 16, 2026 |
Questions about Glenn Gormley
Answered from the filings on this page, as of the latest one.
Is Glenn Gormley buying or selling?
Glenn Gormley has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Glenn Gormley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Glenn Gormley has 0.
Where does Glenn Gormley file Form 4?
Glenn Gormley has filed Form 4 at AKTS (Aktis Oncology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.